3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
112
Recurrence
29
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Neoplasms
14
Neoplasms, Plasma Cell
13
Leukemia
10
Lymphoma, Non-Hodgkin
8
Lymphoma
8
Leukemia, Myeloid, Acute
8
Carcinoma, Non-Small-Cell Lung
8
Lymphoma, Large B-Cell, Diffuse
7
Burkitt Lymphoma
7
Vomiting
6
Prostatic Neoplasms
6
Breast Neoplasms
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasm Metastasis
5
Nausea
5
Lung Neoplasms
5
Pancreatic Neoplasms
3
Lymphoma, Follicular
3
Immunoglobulin Light-chain Amyloidosis
3
Hematologic Neoplasms
3
Hematologic Diseases
3
Glioblastoma
3
Amyloidosis
3
Smoldering Multiple Myeloma
2
Renal Insufficiency
2
Oligodendroglioma
2
Myelodysplastic Syndromes
2
Interventions
Temozolomide
22
Bevacizumab
10
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Irinotecan
5
Carmustine
4
fluorodopa F 18
3
Topotecan
3
Surgical Procedures, Operative
3
Standard of Care
3
Radiosurgery
3
Magnetic Resonance Imaging
3
Congresses as Topic
3
Carboplatin
3
Aminolevulinic Acid
3
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
3
ribociclib
2
poly ICLC
2
fluoromisonidazole
2
carmustine, poliferprosan 20 drug combination
2
cabozantinib
2
Vorinostat
2
TIC10 compound
2
Re-Irradiation
2
Radiotherapy, Intensity-Modulated
2
Panobinostat
2
O(6)-benzylguanine
2
Melphalan
2
Lomustine
2
Lacosamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Glioma
×
Dexamethasone
×
Clear all
NCT04128774
2024-11-26
GBMdexaB
Amsterdam UMC, location VUmc
Terminated
5 enrolled